A detailed history of Whetstone Capital Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Whetstone Capital Advisors, LLC holds 70,065 shares of DXCM stock, worth $5.32 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares
70,065
Previous 10,972 538.58%
Holding current value
$5.32 Million
Previous $1.24 Million 277.57%
% of portfolio
2.26%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $3.78 Million - $6.86 Million
59,093 Added 538.58%
70,065 $4.7 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $5,074 - $6,460
46 Added 0.42%
10,972 $1.24 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $599,769 - $735,665
5,251 Added 92.53%
10,926 $1.52 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $428,405 - $704,608
5,675 New
5,675 $704,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Whetstone Capital Advisors, LLC Portfolio

Follow Whetstone Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whetstone Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whetstone Capital Advisors, LLC with notifications on news.